华纳药厂(688799.SH)获得盐酸异丙肾上腺素注射液药品注册证书

Core Viewpoint - Warner Pharmaceuticals (688799.SH) has received approval from the National Medical Products Administration for the registration certificate of Isoproterenol Hydrochloride Injection, indicating a significant advancement in its product portfolio [1] Group 1: Product Approval - The Isoproterenol Hydrochloride Injection is indicated for the treatment of cardiogenic or infectious shock, complete atrioventricular block, and cardiac arrest [1] - The product has been classified as a Category 3 chemical drug under the new registration classification, which is equivalent to passing the consistency evaluation [1]